講演・口頭発表等 - 長堀　正和

1. T. Fujii , S. Hibiya , H. Shimizu , A. Kawamoto , K. Takenaka , E. Saito , M. Nagahori , K. Ohtsuka , R. Okamoto. DUAL THERAPY WITH CAROTEGRAST (AJM300: ORAL α4 INTEGRIN ANTAGONIST) AND BIOLOGICS FOR REFRACTORY ULCERATIVE COLITIS. UEGW2023 2023.10.15

2. 土屋輝一郎、長堀正和、日比谷秀爾、竹中健人、河本亜美、清水寛路、藤井俊光、齊藤詠子、大塚和朗、渡辺　守、岡本隆一 . 【誌面発表】COVID-19蔓延下におけるスマートデバイスを用いたIBD病診連携に関する研究. 厚生労働科学研究費 難治性疾患政策研究事業 「難治性炎症性腸管障害に関する調査研究」令和3年度 第1回総会 2021.07.15 Web開催

3. Toshimitsu Fujii, Shuji Hibiya, Chiaki Maeyashiki, Eiko Saito, Kento Takenaka, Maiko Motobayashi, Hiromichi Shimizu, Masakazu Nagahori, Kazuo Ohtsuka, Masayuki Kurosaki, Tsunehito Yauchi, Mamoru Watanabe. Intolerance to 5-aminosalicylate is a risk of poor prognosis in Ulcerative colitis patients.. ECCO2020 2020.02.14 Vienna（Austria）

4. 藤井俊光、日比谷秀爾、齊藤詠子、竹中健人、清水寛路、長堀正和、大塚和朗、黒崎雅之、矢内常人、泉 並木、渡辺 守. 潰瘍性大腸炎における5ASA不耐は予後不良因子となる. 日本消化器病関連学会週間(JDDW)2019 2019.11.21 神戸コンベンションセンター

5. Eiko Saito, Kohei Suzuki, Shuuji Hibiya, Maiko Motobayashi, Kento Takenaka, Nobukatsu Horita, Hiromichi Shimizu, Michio Onizawa, Toshimitsu Fujii, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe. The clinical efficacy of ustekinumab (UST) in patients with Crohn’s disease (CD). AOCC2019 2019.06.15 台北

6. Kento Takenaka, Kazuo Ohtsuka, Toshimitsu Fujii, Kohei Suzuki, Hiromichi Shimizu, Maiko Motobayashi, Shuji Hibiya, Eiko Saito, Masakazu Nagahori, Mamoru Watanabe. Small bowel endoscopic healing of Crohn’s disease treated with anti-TNF antibodies. The 7th Annual Meeting of Asian Organization for Crohn's and Colitis (AOCC 2019) 2019.06.15 台北

7. 齊藤詠子、秋山慎太郎、鈴木康平、本林麻衣子、竹中健人、清水寛路、鬼澤道夫、藤井俊光、長堀正和、大塚和朗、渡辺　守. クローン病における抗TNF-α抗体二次無効時のウステキヌマブの治療成績について. 第9回日本炎症性腸疾患学会学術集会 2018.11.22 メルパルク京都（京都府京都市）

8. Takenaka K, Ohtsuka K, Fujii T, Nagahori M, Saito E, Motobayashi M, Suzuki K, Watanabe M. Small bowel mucosal healing of Crohn’s disease treated with anti-TNF antibodies. FALKシンポジウム 2018.09.07 京都ホテルオークラ（京都府京都市）

9. Saito　E, Suzuki K, Shimizu H, Motobayashi M, Takenaka K, Onizawa M, Fujii T, Nagahori M, Ohtsuka K, Watanabe M. The clinical efficacy of switching cases between Infliximab(IFX) andAdalimumab(ADA) in patients with ulcerative colitis. AOCC2018 2018.06.22 Shanghai

10. Ohtsuka K, Takenaka K, Suzuki K, Fujii T, Nagahori M, Matsuoka K, Saito E, Katsukura N, Fukuda M, Araki A, Watanabe M. Usefulness of single-balloon enteroscopy: from a single center 990 experiences. DDW2018 2018.06.03 Washington D.C (USA）

11. Toshimitsu Fujii, Yoshio Kitazume, Kento Takenaka, Maiko Kimura,Eiko Sito, Katsuyoshi Matsuoka, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe. Simplified MR enteroclonography Classification Based on Endoscopic Findings for Activity Assessment of Crohn's Disease. UEGW2017 (欧州消化器病学会週間2017） 2017.11.01 Barcelona(Spain)

12. T. Fujii Y. Kitazume K. Takenaka M. Kimura E. Saito K. Matsuoka M. Nagahori K. Ohtsuka M. Watanabe. Simplified MR enterocolonography Classification Based on Endoscopic Findings for Activity Assessment of Crohn’s Disease. UEGW2017 (欧州消化器病学会週間2017） 2017.11.01 Barcelona(Spain)

13. K. Takenaka K. Ohtsuka Y. Kitazume T. Fujii K. Matsuoka M. Kimura M. Nagahori M. Watanabe. Utility of Magnetic Resonance Evaluation for Small Bowel Endoscopic Healing in Patients with Crohn’s Disease. UEGW2017 (欧州消化器病学会週間2017） 2017.11.01 Barcelona(Spain)

14. Takenaka K, Ohtsuka K, Kitazume Y, Fujii T, Matsuoka K, Kimura M, Nagahori M, Watanabe M. Utility of Magnetic Resonance Evaluation for Small Bowel Endoscopic Healing in Patients with Crohn’s Disease. UEGW2017 (欧州消化器病学会週間2017） 2017.10.30 Barcelona(Spain)

15. Takenaka K, Ohtsuka K, Kitazume Y, Matsuoka K, Fujii T, Nagahori M, Kimura M, Watanabe M.. Magnetic resonance enterography for small bowel mucosal healing in patients with Crohn’s disease.. APDW2017 2017.09.23 Hong Kong Convention and Exhibition Centre（香港）

16. Motobayashi M, Matsuoka K, Iwamoto F, Takenaka K, Fujii T, Nagahori M, Enomoto N, Ohtsuka K, Watanabe M. Correlation of Fecal Calprotectin Levels with Endoscopic Severity Evaluated with Balloon-assisted Endoscopy in Patients with Crohn’s Disease. . AOCC2017 2017.06.17 Seoul, Korea

17. Fujii T, Kitazume Y, Takenaka K, Kimura M, Matsuoka K, Nagahori M, Ohtsuka K, Watanabe M. The 5-point MR enterocolonography classification based on endoscopic findings for activity assessment of Crohn's disease. AOCC2017 2017.06.16 Seoul, Korea

18. Kento Takenaka, Kazuo Ohtsuka, Yoshio Kitazume, Katsuyoshi Matsuoka, Toshimitsu Fujii, Masakazu Nagahori, Maiko Kimura, Mamoru Watanabe. Magnetic resonance evaluation for small bowel endoscopic remission in patients with crohn’s disease.. AOCC2017 2017.06.15 Seoul, Korea

19. Nibe　Y, Oshima S, Aonuma E, Matsuda H, Otsubo K, Maeyashiki C, Kobayashia M, Matsuzawa Y , Nakada S, Watanabe M. Novel polyubiquitin imaging reveals that atypical polyubiquitin contribute to autophagy.. GI research Academy 2017 2017.06.09 経団連会館（東京都千代田区）

20. Toshimitsu Fujii, Kento Takenaka, Maiko Kimura, Katsuyoshi Matsuoka, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe. MR enterocolonography evaluation for small bowel strictures in patients with Crohn’s disease: comparison with balloon enteroscopy. UEGW2016 2016.10.18 VIENNA